In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters

Author:

Fass R J1,Gregory W W1,D'Amato R F1,Matsen J M1,Wright D N1,Young L S1

Affiliation:

1. Department of Internal Medicine, Ohio State University College of Medicine, Columbus 43210.

Abstract

Among 28,000 isolates of the family Enterobacteriaceae and nonfermenters isolated at multiple medical centers, 1,084 (4%) were resistant to cefoperazone (MIC, greater than or equal to 64 micrograms/ml) and 1,711 (6%) exhibited cefoperazone MICs of 2 to 32 micrograms/ml. Ninety-six percent of these 2,795 isolates produced beta-lactamase, as determined by the nitrocefin test. Sulbactam alone (8 micrograms/ml) was inactive against 99.6% of the isolates other than Acinetobacter calcoaceticus and Pseudomonas cepacia. Sulbactam enhanced the activity of cefoperazone against 56% of the isolates of the family Enterobacteriaceae and 44% of the nonfermenters. In the presence of sulbactam concentrations of less than or equal to 8 micrograms/ml, 65% of the cefoperazone-resistant isolates had reductions in cefoperazone MICs of greater than or equal to 2 log2 dilution steps and were susceptible to less than or equal to 32 micrograms/ml. Antagonism was not observed.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference19 articles.

1. Bacterial antibiotic resistance before and after clinical application in the United;Barry A. L.;States. Bull. N. Y. Acad. Med.,1987

2. CP-45,899, a P-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization;English A. R.;Antimicrob. Agents Chemother.,1978

3. Fass R. J. 1981. Inconsistency of synergy between the P-lactamase inhibitor CP-45 899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and Pseudomonas NOTES 2259

4. Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors;Fu K. P.;J. Antimicrob. Chemother.,1980

5. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria;Fuchs P. C.;Diagn. Microbiol. Infect. Dis.,1987

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3